Name: Coming soon: "The Readout LOUD" by STAT
Duration: 1 min 15 s
Description: An introduction to a new weekly biotech podcast from STAT.

This week is a special two-part episode focusing on last week’s controversial — some say inflammatory — decision to approve aducanumab, a new Alzheimer’s drug. In these episodes, I talk with two Alzheimer’s experts with vastly different viewpoints on the news. First up: Dennis J. Selkoe, a physician and scientist whose research is at the core of how Aduhelm works.

Episode 19, Part 1: An original believer on the aducanumab decision

An introduction to a new weekly biotech podcast from STAT.

Coming soon: "The Readout LOUD"

STAT’s weekly biotech podcast, breaking down the latest news, digging deep into industry goings-on, and giving you a preview of the week to come.

Coming soon: "The Readout LOUD"

STAT

Related tracks